Ultrasound-Enhanced Protective Effect of Tetramethylpyrazine against Cerebral Ischemia/Reperfusion Injury

Zhang, Chunbing; Teng, Fengmeng; Tu, Juan; Zhang, Dong
November 2014
PLoS ONE;Nov2014, Vol. 9 Issue 11, p1
Academic Journal
In traditional Chinese medicine, Ligusticum wallichii (Chuan Xiong) and its bioactive ingredient, tetramethylpyrazine (TMP), have been used to treat cardiovascular diseases and to relieve various neurological symptoms, such as those associated with ischemic injury. In the present study, we investigated whether ultrasound (US) exposure could enhance the protective effect of TMP against cerebral ischemia/reperfusion (I/R) injury. Glutamate-induced toxicity to pheochromocytoma (PC12) cells was used to model I/R injury. TMP was paired with US to examine whether this combination could alleviate glutamate-induced cytotoxicity. The administration of TMP effectively protected cells against glutamate-induced apoptosis, which could be further enhanced by US-mediated sonoporation. The anti-apoptotic effect of TMP was associated with the inhibition of oxidative stress and a change in the levels of apoptosis-related proteins, Bcl-2 and Bax. Furthermore, TMP reduced the expression of proinflammatory cytokines such as TNF-α and IL-8, which likely also contributes to its cytoprotective effects. Taken together, our findings suggest that ultrasound-enhanced TMP treatment might be a promising therapeutic strategy for ischemic stroke. Further study is required to optimize ultrasound treatment parameters.


Related Articles

  • Tetramethylpyrazine Analogue CXC195 Protects against Cerebral Ischemia/Reperfusion Injury in the Rat by an Antioxidant Action via Inhibition of NADPH Oxidase and iNOS Expression. Liu, Huiqing; Wei, Xinbing; Chen, Lin; Liu, Xiaoqian; Li, Senpeng; Liu, Xinyong; Zhang, Xiumei // Pharmacology;2013, Vol. 92 Issue 3/4, p198 

    Aims: This study was conducted to investigate the protective effects of CXC195, a tetramethylpyrazine analogue, in acute focal cerebral ischemia/reperfusion (I/R) injury in rats and to elucidate the potential mechanism. Methods: Middle cerebral artery occlusion for 2 h followed by reperfusion...

  • Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Fink, Matthew E. // Neurology Alert;Jun2010, Vol. 28 Issue 10, p80 

    The article discusses research on the safety of tissue plasminogen activator (tPA) in patients who are suffering from neuroimaging-negative cerebral ischemia and stroke, referencing a study by O. Y. Chernyshev and colleagues, published in the 2010 issue of "Neurology."

  • Comparison of Initial Vasopressors Used for Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage. Roy, Bhaskar; McCullough, Louise D.; Dhar, Rajat; Grady, James; Wang, Yu-Bo; Brown, Robert J. // Cerebrovascular Diseases;Jun2017, Vol. 43 Issue 5/6, p266 

    Background: The main reason for morbidity after aneurysmal subarachnoid hemorrhage (aSAH) is delayed cerebral ischemia (DCI). The mainstay of medical therapy for treating DCI is induced hypertension with vasopressors to restore cerebral perfusion. Both phenylephrine (PE) and norepinephrine (NE)...

  • Erratum.  // Cardiology;Jun2016, Vol. 134 Issue 3, p359 

    A correction to the article "Helix B surface peptide protects against acute myocardial ischemia-reperfusion injury via the RISK and SAFE pathways in a mouse model" in volume 134, 2016, is presented.

  • Editorial. Edwards, Hazel // Ultrasound;May2008, Vol. 16 Issue 2, p55 

    The article discusses various reports published within the issue, including one the significant role of echocardiography in evaluating and monitoring heart diseases and another on the appearance of abdominal ultrsonography in human immunodeficiency virus (HIV) patients.

  • Therapeutic effects of traditional herbal medicine on cerebral ischemia: A perspective of vascular protection. Bu, Youngmin; Lee, Kyungjin; Jung, Hyuk-Sang; Moon, Sang-Kwan // Chinese Journal of Integrative Medicine;Nov2013, Vol. 19 Issue 11, p804 

    Although many agents for acute ischemic stroke treatment have been developed from extensive preclinical studies, most have failed in clinical trials. As a result, researchers are seeking other methods or agents based on previous studies. Among the various prospective approaches, vascular...

  • Thrombolytic Therapy for Acute Ischemic Stroke: The Continuing Debate Over the Use of t-Pa. Chiu, Robert // Einstein Quarterly: Journal of Biology & Medicine;1998, Vol. 15 Issue 1, p39 

    Discusses the issues concerning the results of the National Institute of Neurological Disorders and Stroke study on the use of thrombotic treatment with intravenous tissue plasminogen activator (t-Pa) for acute ischemic stroke. Increase in the number of patients with symptomatic cerebral...

  • Glucocorticoid Treatment Does Not Improve Neurological Recovery Following Cardiac Arrest. Jastremski, Michael; Sutton-Tyrell, Kim; Vaagenes, Per; Abramson, Norman; Heiselman, Darell; Safar, Peter // JAMA: Journal of the American Medical Association;12/22/89-12/29/89, Vol. 262 Issue 24, p3427 

    Discusses the effects of glucocorticoid treatment on neurological outcome after global brain ischemia. Use of the database of the Brain Resuscitation Clinical Trial; Suggestion that none of the steroid regimens statistically improved mean group survival rate or neurological recovery rate over...

  • Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury. Yixiu Zhao; Xin Zhang; Jing Luan; Buchang Zhao; Na An; Na Sun; Xinhui Wang; Tao Zhao; Yanhong Sun; Zidong Donna Fu; Yan Zhang; Baofeng Yang // Cellular Physiology & Biochemistry (Karger AG);Aug2018, Vol. 48 Issue 6, p2503 

    Background/Aims: Shenxian-shengmai (SXSM) oral liquid, a Chinese patent compound medicine, has been used to treat sinus bradyarrhythmias induced by mild sick sinus syndrome in clinical practice. Myocardial ischemia, in particular in serious or right coronary-related heart diseases, can cause...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics